Psychosis in Alzheimer's disease is associated with specific changes in brain MRI volume, cognition and neuropathology

Neurobiol Aging. 2024 Jun:138:10-18. doi: 10.1016/j.neurobiolaging.2024.02.013. Epub 2024 Mar 2.

Abstract

Psychosis in Alzheimer's Disease (AD) is prevalent and indicates poor prognosis. However, the neuropathological, cognitive and brain atrophy patterns underlying these symptoms have not been fully elucidated. In this study, we evaluated 178 patients with AD neuropathological change (ADNC) and ante-mortem volumetric brain magnetic resonance imaging (MRI). Presence of psychosis was determined using the Neuropsychiatric Inventory Questionnaire. Clinical Dementia Rating Sum-of-boxes (CDR-SB) was longitudinally compared between groups with a follow-up of 3000 days using mixed-effects multiple linear regression. Neuropsychological tests closest to the time of MRI and brain regional volumes were cross-sectionally compared. Psychosis was associated with lower age of death, higher longitudinal CDR-SB scores, multi-domain cognitive deficits, higher neuritic plaque severity, Braak stage, Lewy Body pathology (LB) and right temporal lobe regional atrophy. Division according to the presence of LB showed differential patterns of AD-typical pathology, cognitive deficits and regional atrophy. In conclusion, psychosis in ADNC with and without LB has clinical value and associates with subgroup patterns of neuropathology, cognition and regional atrophy.

Keywords: Alzheimer’s disease; Brain imaging; Lewy body pathology; MRI; Psychosis.

MeSH terms

  • Alzheimer Disease* / diagnosis
  • Atrophy / pathology
  • Brain / diagnostic imaging
  • Brain / pathology
  • Cognition
  • Humans
  • Magnetic Resonance Imaging / methods
  • Psychotic Disorders* / diagnostic imaging